Awad, Mark M <br/><br/>
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Mar 2016 
 - 721-30 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2015.63.4600  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Crizotinib<br/>Exons<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--drug therapy<br/>Middle Aged<br/>Mutation<br/>Neoplasm Staging<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins c-met--genetics<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Real-Time Polymerase Chain Reaction<br/>Risk Factors